--- title: "Profusa submits advance notice to Ascent for up to 9.99% equity purchase with true-up mechanism" type: "News" locale: "en" url: "https://longbridge.com/en/news/286822292.md" description: "Profusa has submitted an advance notice to Ascent Partners Fund for the purchase of up to 9.99% of its outstanding shares, capped at $300,000. The purchase price will be based on 97% of the lowest 10-day VWAP, with a true-up mechanism to issue additional shares if necessary. This is part of their equity line agreement." datetime: "2026-05-18T21:33:01.000Z" locales: - [zh-CN](https://longbridge.com/zh-CN/news/286822292.md) - [en](https://longbridge.com/en/news/286822292.md) - [zh-HK](https://longbridge.com/zh-HK/news/286822292.md) --- # Profusa submits advance notice to Ascent for up to 9.99% equity purchase with true-up mechanism **Profusa requested Ascent Partners Fund to purchase shares under their equity line with new pricing and true-up terms.** **Key Highlights:** - Submitted Advance Notice asking Ascent to buy up to 9.99% of outstanding shares per notice, capped at $300,000. - Purchase price funded upon delivery of shares; Ascent remits within one trading day 97% of the lowest 10-day VWAP times shares. - Includes a True-Up Mechanism: if 97% of the lowest VWAP during the Adjustment Period is below the closing price, Profusa will issue additional shares so Ascent receives the equivalent number. Original SEC Filing: Profusa, Inc. \[ PFSA \] - 8-K - May. 18, 2026 **Disclaimer** This is an AI-powered summary. It may contain inaccuracies. Consider verifying important information with the source. Please note this summary is solely based on documents filed with the SEC. ### Related Stocks - [PFSA.US](https://longbridge.com/en/quote/PFSA.US.md) - [BBH.US](https://longbridge.com/en/quote/BBH.US.md) - [PBE.US](https://longbridge.com/en/quote/PBE.US.md) - [LABU.US](https://longbridge.com/en/quote/LABU.US.md) - [IBB.US](https://longbridge.com/en/quote/IBB.US.md) - [FBT.US](https://longbridge.com/en/quote/FBT.US.md) - [XBI.US](https://longbridge.com/en/quote/XBI.US.md) - [BIB.US](https://longbridge.com/en/quote/BIB.US.md) - [SBIO.US](https://longbridge.com/en/quote/SBIO.US.md) - [NVACW.US](https://longbridge.com/en/quote/NVACW.US.md) ## Related News & Research - [Co-Diagnostics Advances Ebola Preparedness With New Bundibugyo Virus Assay Strategy; Stock Up](https://longbridge.com/en/news/286956797.md) - [Regenxbio's muscle disorder therapy meets main goal in late-stage study](https://longbridge.com/en/news/286406339.md) - [Lantern Pharma raises capital, plans AI platform spinoff](https://longbridge.com/en/news/286480334.md) - [Genprex data shows gene therapy reverses hyperglycemia in T2D mice at ASGCT](https://longbridge.com/en/news/286414681.md) - [US cancer clinics scramble to get experimental Revolution Medicines pancreatic cancer drug](https://longbridge.com/en/news/286394551.md)